Product Information
COLESEVELAM 625 MG TABLET is a generic product labeled by Cranbury Pharmaceuticals, LLC, priced at $0.2705 per EA under NDC 27808019001. Its NADAC has been published 268 times since May 12, 2021.
Strength
625 mg/1
Manufacturer
Cranbury Pharmaceuticals, LLCNDC
27808019001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
COLESEVELAM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209946On Market Since
10/19/2020
Pharmacological Classes
Price Statistics
The NADAC for COLESEVELAM 625 MG TABLET has been published 268 times since May 12, 2021, and over the history we have for it it has declined 51.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2705 per EA |
|---|---|
| All-time high | $0.5623 (May 12, 2021) |
| All-time low | $0.1763 (Jul 17, 2024) |
| 52-week high | $0.3117 |
| 52-week low | $0.2660 |
| Median price | $0.2874 |
| Average price | $0.3252 |
| Largest weekly change | +56.2% (May 17, 2023) |
| Weeks tracked | 268 |
| Tracking since | May 12, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Colesevelam hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of COLESEVELAM 625 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for COLESEVELAM 625 MG TABLET, manufactured by Cranbury Pharmaceuticals, LLC, is $0.2705 per EA (NDC 27808019001), effective Jun 24, 2026.
How has the price of COLESEVELAM 625 MG TABLET changed over time?
Over the history we have for it, the NADAC for COLESEVELAM 625 MG TABLET has declined 51.9%. It has been tracked across 268 weekly CMS publications since May 12, 2021.
What are the highest and lowest recorded NADAC prices for COLESEVELAM 625 MG TABLET?
Since May 12, 2021, the NADAC for COLESEVELAM 625 MG TABLET has ranged from a low of $0.1763 (Jul 17, 2024) to a high of $0.5623 (May 12, 2021), with a median of $0.2874 per EA.
Are there cheaper alternatives to COLESEVELAM 625 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of COLESEVELAM 625 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures COLESEVELAM 625 MG TABLET?
COLESEVELAM 625 MG TABLET (NDC 27808019001) is labeled by Cranbury Pharmaceuticals, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification